The latest closing stock price for Spero Therapeutics as of September 18, 2024 is 1.34.
An investor who bought $1,000 worth of Spero Therapeutics stock at the IPO in 2017 would have $-883 today, roughly -1 times their original investment - a -26.44% compound annual growth rate over 7 years.
The all-time high Spero Therapeutics stock closing price was 22.07 on December 28, 2020.
The Spero Therapeutics 52-week high stock price is 1.89, which is 41% above the current share price.
The Spero Therapeutics 52-week low stock price is 0.99, which is 26.1% below the current share price.
The average Spero Therapeutics stock price for the last 52 weeks is 1.40.
An investor who bought $1,000 worth of Spero Therapeutics stock at the IPO in 2017 would have $-883 today, roughly -1 times their original investment - a -26.44% compound annual growth rate over 7 years.
The all-time high Spero Therapeutics stock closing price was 22.07 on December 28, 2020.
The Spero Therapeutics 52-week high stock price is 1.89, which is 41% above the current share price.
The Spero Therapeutics 52-week low stock price is 0.99, which is 26.1% below the current share price.
The average Spero Therapeutics stock price for the last 52 weeks is 1.40.